Merus N.V (NASDAQ: MRUS) on Monday, soared 4.39% from the previous trading day, before settling in for the closing price of $56.07. Within the past 52 weeks, MRUS’s price has moved between $33.19 and $61.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 3.02% over the past five years. The company achieved an average annual earnings per share of -44.81%. With a float of $61.63 million, this company’s outstanding shares have now reached $69.18 million.
Let’s look at the performance matrix of the company that is accounted for 260 employees. In terms of profitability, gross margin is 100.0%, operating margin of -549.95%, and the pretax margin is -490.46%.
Merus N.V (MRUS) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Merus N.V is 10.96%, while institutional ownership is 96.40%. The most recent insider transaction that took place on Mar 21 ’25, was worth 193,990. In this transaction VP Controller, PAO of this company sold 4,000 shares at a rate of $48.50, taking the stock ownership to the 11,002 shares. Before that another transaction happened on Aug 21 ’24, when Company’s VP Controller, PAO sold 2,500 for $54.00, making the entire transaction worth $135,000. This insider now owns 7,002 shares in total.
Merus N.V (MRUS) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -44.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.98% during the next five years compared to -8.04% drop over the previous five years of trading.
Merus N.V (NASDAQ: MRUS) Trading Performance Indicators
Merus N.V (MRUS) is currently performing well based on its current performance indicators. A quick ratio of 5.86 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 74.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.12, a number that is poised to hit -1.14 in the next quarter and is forecasted to reach -4.67 in one year’s time.
Technical Analysis of Merus N.V (MRUS)
Merus N.V (NASDAQ: MRUS) saw its 5-day average volume 2.15 million, a positive change from its year-to-date volume of 0.89 million. As of the previous 9 days, the stock’s Stochastic %D was 91.76%. Additionally, its Average True Range was 3.79.
During the past 100 days, Merus N.V’s (MRUS) raw stochastic average was set at 97.69%, which indicates a significant increase from 96.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 133.23% in the past 14 days, which was higher than the 75.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.87, while its 200-day Moving Average is $46.17. Nevertheless, the first resistance level for the watch stands at $59.82 in the near term. At $61.11, the stock is likely to face the second major resistance level. The third major resistance level sits at $63.08. If the price goes on to break the first support level at $56.55, it is likely to go to the next support level at $54.58. The third support level lies at $53.29 if the price breaches the second support level.
Merus N.V (NASDAQ: MRUS) Key Stats
Market capitalization of the company is 4.05 billion based on 69,214K outstanding shares. Right now, sales total 36,130 K and income totals -215,330 K. The company made 26,490 K in profit during its latest quarter, and -96,470 K in sales during its previous quarter.
